The bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 1045-1050

  Holweg, Alexander ^a   Schnare, Markus ^b   Gessner, André ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Antimicrobial peptide; Bactericidal permeability increasing protein (BPI); Cystic fibrosis; Lung innate immunity; Pneumonia

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN;

AIRWAY; CONFERENCE PAPER; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EPITHELIUM; EXPERIMENTAL STUDY; HUMAN; INNATE IMMUNITY; LOBAR PNEUMONIA; LUNG INFECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CYSTIC FIBROSIS; HUMANS; IMMUNITY, INNATE; PNEUMONIA, BACTERIAL; RESPIRATORY SYSTEM;

GRANULA; NEGIBACTERIA;

EID: 79960857756     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391045     Document Type: Conference Paper

References (59)

1. Zhang, P., Summer, W.R., Bagby, G.J. and Nelson, S. (2000) Innate immunity and pulmonary host defense. Immunol. Rev. 173, 39-51
2. Mizgerd, J.P. (2008) Acute lower respiratory tract infection. N. Engl. J. Med. 358, 716-727
3. Mizgerd, J.P. (2006) Lung infection: a public health priority. PLoS Med. 3, e76
4. Rogan, M.P., Geraghty, P., Greene, C.M., O'Neill, S.J., Taggart, C.C. and McElvaney, N.G. (2006) Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir. Res. 7, 29
5. Balamayooran, G., Batra, S., Fessler, M.B., Happel, K.I. and Jeyaseelan, S. (2010) Mechanisms of neutrophil accumulation in the lungs against bacteria. Am. J. Respir. Cell Mol. Biol. 43, 5-16
6. Weiss, J., Elsbach, P., Olsson, I. and Odeberg, H. (1978) Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253, 2664-2672
7. Weiss, J. and Olsson, I. (1987) Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood 69, 652-659 (Pubitemid 17022043)
8. Calafat, J., Janssen, H., Tool, A., Dentener, M.A., Knol, E.F., Rosenberg, H.F. and Egesten, A. (1998) The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood 91, 4770-4775 (Pubitemid 28270328)
9. Canny, G. and Levy, O. (2008) Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites. Trends Immunol. 29, 541-547
10. 2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J. Biol. Chem. 262, 14891-14894
11. Marra, M.N., Wilde, C.G., Griffith, J.E., Snable, J.L. and Scott, R.W. (1990) Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144, 662-666 (Pubitemid 20036099)
12. Ooi, C.E., Weiss, J., Doerfler, M.E. and Elsbach, P. (1991) Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability- increasing protein of human neutrophils. J. Exp. Med. 174, 649-655
13. Gazzano-Santoro, H., Parent, J.B., Grinna, L., Horwitz, A., Parsons, T., Theofan, G., Elsbach, P., Weiss, J. and Conlon, P.J. (1992) High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60, 4754-4761
14. Gazzano-Santoro, H., Meszaros, K., Birr, C., Carroll, S.F., Theofan, G., Horwitz, A.H., Lim, E., Aberle, S., Kasler, H. and Parent, J.B. (1994) Competition between rBPI23, a recombinant fragment of bactericidal/permeability- increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and Gram-negative bacteria. Infect. Immun. 62, 1185-1191
15. Schultz, H. and Weiss, J.P. (2007) The bactericidal/permeability- increasing protein (BPI) in infection and inflammatory disease. Clin. Chim. Acta 384, 12-23
16. Weersink, A.J., van Kessel, K.P., van den Tol, M.E., van Strijp, J.A., Torensma, R., Verhoef, J., Elsbach, P. and Weiss, J. (1993) Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. J. Immunol. 150, 253-263 (Pubitemid 23069802)
17. Aichele, D., Schnare, M., Saake, M., Rollinghoff, M. and Gessner, A. (2006) Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect. Immun. 74, 4708-4714
18. 2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Invest. 90, 1122-1130
19. Peleg, A.Y. and Hooper, D.C. (2010) Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 362, 1804-1813
20. Nathe, K.E., Parad, R., Van Marter, L.J., Lund, C.A., Suter, E.E., Hernandez-diaz, S., Boush, E.B., Ikonomu, E., Gallington, L., Morey, J.A. et al. (2009) Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatr. Res. 66, 191-196
21. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y. and Zychlinsky, A. (2004) Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (Pubitemid 38314426)
22. Urban, C.F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., Brinkmann, V., Jungblut, P.R. and Zychlinsky, A. (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5, e1000639
23. Papayannopoulos, V. and Zychlinsky, A. (2009) NETs: a new strategy for using old weapons. Trends Immunol. 30, 513-521
24. Levy, O., Martin, S., Eichenwald, E., Ganz, T., Valore, E., Carroll, S.F., Lee, K., Goldmann, D. and Thorne, G.M. (1999) Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability- increasing protein. Pediatrics 104, 1327-1333
25. Berkestedt, I., Herwald, H., Ljunggren, L., Nelson, A. and Bodelsson, M. (2010) Elevated plasma levels of antimicrobial polypeptides in patients with severe sepsis. J. Innate Immun. 2, 478-482
26. Calvano, S.E., Thompson, W.A., Marra, M.N., Coyle, S.M., de Riesthal, H.F., Trousdale, R.K., Barie, P.S., Scott, R.W., Moldawer, L.L. and Lowry, S.F. (1994) Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch. Surg. 129, 220-226
27. Rintala, E., Peuravuori, H., Pulkki, K., Voipio-Pulkki, L.M. and Nevalainen, T. (2000) Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome. Intensive Care Med. 26, 1248-1251
28. Canny, G., Levy, O., Furuta, G.T., Narravula-Alipati, S., Sisson, R.B., Serhan, C.N. and Colgan, S.P. (2002) Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. U.S.A. 99, 3902-3907
29. Canny, G.O., Trifonova, R.T., Kindelberger, D.W., Colgan, S.P. and Fichorova, R.N. (2006) Expression and function of bactericidal/permeability- increasing protein in human genital tract epithelial cells. J. Infect. Dis. 194, 498-502
30. Schultz, H., Hume, J., Zhang, D.S., Gioannini, T.L. and Weiss, J.P. (2007) A novel role for the bactericidal/permeability increasing protein in interactions of Gram-negative bacterial outer membrane blebs with dendritic cells. J. Immunol. 179, 2477-2484
31. Evans, T.J., Carpenter, A., Moyes, D., Martin, R. and Cohen, J. (1995) Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of Gram-negative sepsis. J. Infect. Dis. 171, 153-160
32. Alexander, S., Bramson, J., Foley, R. and Xing, Z. (2004) Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/ permeability-increasing protein. Blood 103, 93-99 (Pubitemid 38029923)
33. Chen, J., Li, C., Guan, Y., Kong, Q., Guo, X., Chen, Q., Jing, X., Lv, Z. and An, Y. (2007) Protection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene delivery. Antimicrob. Agents Chemother. 51, 724-731
34. Li, C., Li, J., Lv, Z., Guo, X., Chen, Q., Kong, Q. and An, Y. (2006) Protection of mice from lethal endotoxemia by chimeric human BPI-Fcγ1 gene delivery. Cell. Mol. Immunol. 3, 221-225
35. Srivastava, A., Casey, H., Johnson, N., Levy, O. and Malley, R. (2007) Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease. Infect. Immun. 75, 342-349
36. Eckert, M., Wittmann, I., Rollinghoff, M., Gessner, A. and Schnare, M. (2006) Endotoxin-induced expression of murine bactericidal permeability/ increasing protein is mediated exclusively by Toll/IL-1 receptor domain-containing adaptor inducing IFN-β-dependent pathways. J. Immunol. 176, 522-528
37. Lennartsson, A., Pieters, K., Vidovic, K. and Gullberg, U. (2005) A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow. J. Leukocyte Biol. 77, 369-377 (Pubitemid 40289567)
38. Wittmann, I., Schonefeld, M., Aichele, D., Groer, G., Gessner, A. and Schnare, M. (2008) Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and Gram-negative bacteria. J. Immunol. 180, 7546-7552
39. Davis, P.B., Drumm, M. and Konstan, M.W. (1996) Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154, 1229-1256
40. Campodonico, V.L., Gadjeva, M., Paradis-Bleau, C., Uluer, A. and Pier, G.B. (2008) Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol. Med. 14, 120-133
41. Faure, K., Sawa, T., Ajayi, T., Fujimoto, J., Moriyama, K., Shime, N. and Wiener-Kronish, J.P. (2004) TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 5, 1
42. Gibson, R.L., Burns, J.L. and Ramsey, B.W. (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168, 918-951
43. Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V., Zasloff, M. and Wilson, J.M. (1998) Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102, 874-880
44. Chen, C.I., Schaller-Bals, S., Paul, K.P., Wahn, U. and Bals, R. (2004) β-Defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cystic Fibrosis 3, 45-50
45. Bingle, C.D. and Craven, C.J. (2002) PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11, 937-943
46. Roxo-Rosa, M., da Costa, G., Luider, T.M., Scholte, B.J., Coelho, A.V., Amaral, M.D. and Penque, D. (2006) Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Proteomics 6, 2314-2325
47. Garcia-Caballero, A., Rasmussen, J.E., Gaillard, E., Watson, M.J., Olsen, J.C., Donaldson, S.H., Stutts, M.J. and Tarran, R. (2009) SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc. Natl. Acad. Sci. U.S.A. 106, 11412-11417
48. Marcos, V., Zhou, Z., Yildirim, A.O., Bohla, A., Hector, A., Vitkov, L., Wiedenbauer, E.M., Krautgartner, W.D., Stoiber, W., Belohradsky, B.H. et al. (2010) CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat. Med. 16, 1018-1023
49. Hoiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O. and Kharazmi, A. (2001) Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3, 23-35
50. Kobayashi, H. (2005) Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Treat. Respir. Med. 4, 241-253
51. Hoiby, N. (2002) Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J. Cystic Fibrosis 1, 249-254
52. Aebi, C., Theiler, F., Aebischer, C.C. and Schoeni, M.H. (2000) Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization. Pediatr. Infect. Dis. J. 19, 207-212
53. Dorlochter, L., Carlsson, M., Olafsdottir, E.J., Roksund, O.D., Rosendahl, K. and Fluge, G. (2004) Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. J. Cystic Fibrosis 3, 179-183 (Pubitemid 39194073)
54. Carlsson, M., Eriksson, L., Erwander, I., Wieslander, J. and Segelmark, M. (2003) Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin. Exp. Rheumatol. 21, S95-S100
55. Carlsson, M., Eriksson, L., Pressler, T., Kornfalt, R., Mared, L., Meyer, P., Wiik, A., Wieslander, J. and Segelmark, M. (2007) Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. J. Cystic Fibrosis 6, 228-233 (Pubitemid 46567795)
56. Schultz, H., Schinke, S., Mosler, K., Herlyn, K., Schuster, A. and Gross, W.L. (2004) BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5α in vitro. Pediatr. Pulmonol. 37, 158-164 (Pubitemid 38120986)
57. Zhao, M.H., Jayne, D.R., Ardiles, L.G., Culley, F., Hodson, M.E. and Lockwood, C.M. (1996) Autoantibodies against bactericidal/ permeability- increasing protein in patients with cystic fibrosis. QJM 89, 259-265
58. Sediva, A., Bartunkova, J., Bartosova, J., Jennette, C., Falk, R.J. and Jethwa, H.S. (2003) Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa. Microbes Infect. 5, 27-30 (Pubitemid 36197944)
59. Smith, J.J., Travis, S.M., Greenberg, E.P. and Welsh, M.J. (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236 (Pubitemid 26118164)